EUDAMED’s first four modules become mandatory on 28 May 2026 - what this means for medical device manufacturers
The European Commission (EC) has formally declared that the first four modules of EUDAMED - the European Database on Medical Devices - will become mandatory as of 28 May 2026.
MedNet EC-REP
Author

Which modules are affected
Starting on 28 May 2026, the following modules will require compulsory use under Regulation (EU) 2024/1860:
- Actor registration (registration of economic operators - manufacturers, authorised representatives, importers, etc.)
- UDI/Devices registration (device registration and unique device identifier requirements)
- Notified Bodies & Certificates (registration of notified bodies and associated device certificates)
- Market Surveillance (module supporting oversight of devices on the market)
Timing and transition
The EC published the notice declaring functionality of these modules on 27 November 2025, triggering the mandated six-month transition period under the Regulation - hence the effective date of 28 May 2026.
Until that date, use of the modules remains voluntary, but after 28 May 2026 their use becomes a legal requirement for any responsible economic operator under MDR/IVDR.
Conclusions & Recommendations
- The mandatory activation of the first four EUDAMED modules from 28 May 2026 signals a major shift toward increased transparency and regulatory compliance across the EU medical device market.
- All manufacturers, authorised representatives, importers, and notified bodies should review their readiness - including internal processes and data - to ensure timely registration.
- With our expertise, MedNet EC-REP GmbH can help navigate the transition smoothly. Contact your Regulatory Affairs Manager for further information.
Source: European Commission
Related Articles

MHRA Consultation 2026: The Fee Increases Coming for Medical Device Manufacturers in 2027
The MHRA has opened a consultation on fee increases from April 2027 — including a proposed 70% rise in the post-market surveillance fee. Manufacturers have until 25 September to respond.

New EU Study: Where Manufacturers and Authorised Representatives Really Stand on MDR and IVDR
New EU study finds 48% of manufacturers have withdrawn devices from the market. Key MDR/IVDR and AR findings for 2026. Read the numbers now.

Well-Established Technologies Under the MDR: EU Commission Expands Exemption List
The EU Commission has expanded the WET list under the MDR, easing requirements for certain class II and class III devices.
Stay Updated
Get the latest regulatory updates and industry insights delivered to your inbox.
Subscribe to Updates